Navigation Links
Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights

cribed under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 19, 2009. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future.

                                OMEROS CORPORATION
                           (A Development Stage Company)
                  (In thousands, except share and per share data)
                                                                  Period from
                                                                   June 16,
                          Three Months            Nine Months    (Inception)
                              Ended                  Ended          through
                          September 30,          September 30,   September 30,
                          ---------------        ----------------
                         2009       2008        2009        2008         2009
                         ----       ----        ----        ----         ----
    Grant revenue        $442       $501      $1,010        $989       $4,403
    Research and
     development        3,692      4,737      12,291      12,755       74,525
    Acquired in-
     research and
     development            -          -           -           -       10,891
    General and
     administrative     1,277      3,428       4,162       6,327       36,645
                        -----      -----       -----       -----       ------
     expenses           4,969      8,165      16,453      19,082  
SOURCE Omeros Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
2. Omeros Appoints David A. Mann to its Board of Directors
3. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
4. Omeros and BlueCrest Announce $20 Million Debt Facility
5. Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
6. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
7. Omeros Appoints New Vice President of Clinical Development
8. Omeros Announces Positive Clinical Results of Phase 1/Phase 2 Trial of OMS302 for Use During Ophthalmologic Surgery
9. Omeros Commences Initial Public Offering of Common Stock
10. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
11. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
Post Your Comments:
(Date:7/28/2014)... 2014 According to ... (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic), Applications (Pharmaceutical, Diagnostic, ... Characterization) - Global Forecasts to 2019" published ... estimated at $896.5 Million in 2014 and ... 2019, growing at a CAGR of 5.9% ...
(Date:7/28/2014)... , July 28, 2014   Propeller Health ... disease, announced the hire of Brad Towle ... will be responsible for driving the company,s sales growth, ... experience in healthcare, and specifically his past role in ... to the company at this pivotal time in the ...
(Date:7/28/2014)... San Francisco, California (PRWEB) July 28, 2014 ... reach USD 604.40 billion by 2020, according to a ... scope coupled with the rising demand for effective vaccines ... to patients with unmet medical needs is expected to ... addition, the need to enhance agricultural productivity via the ...
(Date:7/28/2014)... Research and Markets has announced the ... report to their offering. ... technique used to determine the size of a particle in ... to analyze the size of particles as it can affect ... performed to determine the behavior and nature of a material, ...
Breaking Biology Technology:Microbial Identification Market worth $1,194.1 Million by 2019 2Microbial Identification Market worth $1,194.1 Million by 2019 3Propeller Health Hires Brad Towle as Senior Vice President of Business and Client Development 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Global Particle Size Analysis Market 2014-2018 2
... Fla. , April 23 Moffitt Cancer Center announces ... for selecting chemotherapy for Non Small Lung Cancer patients.  Each year, ... , , ... ERCC1 levels in cells to predict response to cisplatin-based chemotherapy.   ...
... April 22 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" ... a complaint regarding its proposed merger with Datong Investment Inc ... Circuit for Palm Beach County , State of ... Yanlin Han , a director and Chief Executive Officer ...
... ... role of natural resources in food production. Technologies that grow more from less improve ... (PRWEB) ... has become a founding member of the Sustainability Consortium , an independent group ...
Cached Biology Technology:Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 2Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 3Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 4Complaint Filed Regarding Proposed Merger 2Complaint Filed Regarding Proposed Merger 3Complaint Filed Regarding Proposed Merger 4Syngenta joins Sustainability Consortium as Founding Member 2Syngenta joins Sustainability Consortium as Founding Member 3
(Date:7/28/2014)... powerful new tool that can help advance the ... and renewable bioenergy, has been developed by researchers ... BioEnergy Institute (JBEI), a multi-institutional partnership led by ... researchers have developed an assay that enables scientists ... sugar transporters, critical components in the biosynthesis of ...
(Date:7/28/2014)... The Wyss Institute for Biologically Inspired Engineering at ... technology will be commercialized by a newly formed ... cosmetic, and personalized medicine products. The ... Office of Technology Development (OTD) and the start-up ... Institute,s automated human Organs-on-Chips platform. , "This ...
(Date:7/27/2014)... have survived the asteroid strike that wiped them out ... in history, scientists say. , A fresh study using ... palaeontologists to build a new narrative of the prehistoric ... found that in the few million years before a ... experiencing environmental upheaval. This included extensive volcanic activity, changing ...
Breaking Biology News(10 mins):How sweet it is 2How sweet it is 3Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3Dinosaurs fell victim to perfect storm of events, study shows 2
... is part of a research team breaking new ground in ... $2.5 million grant from the National Institutes of Health, the ... for Xerostomia, or dry mouth, an inevitable consequence of radiation ... project is a collaborative effort between researchers at Rice University, ...
... Ore. Many studies have found that high levels of ... poor fitness and reduced chance of survival but recent ... be a good thing, often the difference between life and ... glucocorticoid hormones, which are part of the natural response to ...
... have identified 38 new genetic regions that are associated with ... total number of genetic regions associated with glucose and insulin ... type 2 diabetes. The researchers used a technology ... to follow-up on genome-wide association results. This technology, Metabochip, was ...
Cached Biology News:UD partner in NIH research project to produce artificial salivary glands 2UD partner in NIH research project to produce artificial salivary glands 3For young birds, getting stressed out can be a good thing 2Metabolic MAGIC 2Metabolic MAGIC 3
... These versatile vacuum cups provide ... smooth, curved, or irregular surfaces. ,PFG: ... Short Bellows cup ,PCG: Multiple Bellows ... typically from 25 to 200 mm ...
Curcumin is an extract of turmeric root with antioxidant, anti-tumor promoter, and anti-inflammatory properties. Curcumin inhibits the induction of NOS in macrophages....
UGT1A6 (D-20)...
... the smallest electronic pressure controller available measuring ... configured this unit specifically for the analytical ... in carrier gas flow control, microfluidic flow ... hydro-dynamic focusing, the OEM-EPC offers external pressure ...
Biology Products: